But a rather sobering account last week shows how most people who stop taking the drugs regain their weight and lose other benefits they saw while on the medicines
Coverage Disclaimer: Insurance coverage policies change frequently and vary by plan, employer, state, and individual circumstances
The medications remain covered for conditions like diabetes and heart disease but not for obesity itself
The Business Group on Health survey found that among companies that cover GLP-1s for weight management, 10% are unlikely or very unlikely to continue the coverage in 2027 for cost reasons, according to Magda Rusinowski, vice president of the non-profit, which represents employers' perspectives on health-related issues
Storage: Keep the pre-filled pen stored properly as directed on the packaging
Key points Glucagon-like peptide 1 (GLP1) receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor are widely expressed in multiple organs beyond the pancreas